BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2261168)

  • 1. Graves' ophthalmopathy--a clinical review.
    Carter JN
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' ophthalmopathy.
    Barrie WE
    West J Med; 1993 Jun; 158(6):591-5. PubMed ID: 8337853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graves' ophthalmopathy].
    Badelon I; Morax S
    Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysthyroid optic neuropathy. Apropos of 2 cases].
    Domenjôd M; Merle H; Gerard M; Ayeboua L; Poman G
    J Fr Ophtalmol; 1996; 19(8-9):543-50. PubMed ID: 8944137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-rosette formation in Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ
    Invest Ophthalmol Vis Sci; 1979 Dec; 18(12):1245-51. PubMed ID: 92464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric aspects in Graves' orbitopathy.
    Gogakos AI; Boboridis K; Krassas GE
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic evaluation of Graves' ophthalmopathy.
    Bahn RS; Garrity JA; Bartley GB; Gorman CA
    Endocrinol Metab Clin North Am; 1988 Sep; 17(3):527-45. PubMed ID: 3065079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What the internist should know about the ophthalmopathy of Graves' disease.
    Hamburger JI; Sugar HS
    Arch Intern Med; 1972 Jan; 129(1):131-9. PubMed ID: 5066655
    [No Abstract]   [Full Text] [Related]  

  • 20. Graves' ophthalmopathy in childhood and adolescence.
    Uretsky SH; Kennerdell JS; Gutai JP
    Arch Ophthalmol; 1980 Nov; 98(11):1963-4. PubMed ID: 6893665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.